Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 17 | 2025 | 1068 | 3.920 |
Why?
|
| Cell Movement | 12 | 2025 | 640 | 3.830 |
Why?
|
| Transforming Growth Factor beta1 | 5 | 2018 | 97 | 1.750 |
Why?
|
| rac1 GTP-Binding Protein | 3 | 2025 | 47 | 1.600 |
Why?
|
| Transforming Growth Factor beta | 4 | 2016 | 214 | 1.600 |
Why?
|
| Cell Proliferation | 10 | 2019 | 1420 | 1.430 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 2 | 2025 | 4 | 1.320 |
Why?
|
| Prostate | 5 | 2018 | 152 | 1.230 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 2019 | 24 | 1.100 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 2 | 2018 | 13 | 0.920 |
Why?
|
| Cell Line, Tumor | 12 | 2025 | 2598 | 0.880 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2018 | 297 | 0.790 |
Why?
|
| Signal Transduction | 9 | 2025 | 2111 | 0.790 |
Why?
|
| Nodal Protein | 2 | 2012 | 2 | 0.740 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2019 | 933 | 0.700 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 62 | 0.590 |
Why?
|
| Oxytocin | 3 | 2018 | 24 | 0.560 |
Why?
|
| Phosphorylation | 7 | 2020 | 973 | 0.560 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 59 | 0.540 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2016 | 82 | 0.490 |
Why?
|
| Male | 17 | 2025 | 22779 | 0.490 |
Why?
|
| Smad3 Protein | 2 | 2012 | 12 | 0.470 |
Why?
|
| Smad2 Protein | 2 | 2012 | 11 | 0.470 |
Why?
|
| Androgens | 2 | 2020 | 107 | 0.430 |
Why?
|
| RNA, Messenger | 6 | 2018 | 1265 | 0.420 |
Why?
|
| RNA, Small Interfering | 5 | 2020 | 436 | 0.410 |
Why?
|
| Epidermal Growth Factor | 3 | 2020 | 69 | 0.400 |
Why?
|
| Dinoprostone | 1 | 2013 | 69 | 0.400 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2012 | 9 | 0.390 |
Why?
|
| Blotting, Western | 5 | 2012 | 884 | 0.380 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2012 | 28 | 0.380 |
Why?
|
| Cell Hypoxia | 1 | 2012 | 57 | 0.380 |
Why?
|
| Carcinoma | 1 | 2013 | 106 | 0.370 |
Why?
|
| Humans | 19 | 2025 | 42163 | 0.370 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 180 | 0.350 |
Why?
|
| Neoplasm Invasiveness | 3 | 2018 | 284 | 0.340 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 228 | 0.340 |
Why?
|
| Oxytocics | 1 | 2010 | 8 | 0.340 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 255 | 0.330 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 649 | 0.320 |
Why?
|
| Neoplastic Stem Cells | 1 | 2011 | 94 | 0.320 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 557 | 0.300 |
Why?
|
| Testosterone | 1 | 2008 | 211 | 0.270 |
Why?
|
| Cholesterol | 1 | 2008 | 230 | 0.260 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2025 | 3 | 0.230 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2025 | 2 | 0.230 |
Why?
|
| Cells, Cultured | 3 | 2012 | 1617 | 0.200 |
Why?
|
| Receptors, Oxytocin | 2 | 2012 | 9 | 0.180 |
Why?
|
| Wound Healing | 2 | 2012 | 82 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 1112 | 0.170 |
Why?
|
| Cell Adhesion | 2 | 2012 | 237 | 0.160 |
Why?
|
| Aminoquinolines | 1 | 2020 | 17 | 0.160 |
Why?
|
| Sirolimus | 1 | 2020 | 70 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 188 | 0.150 |
Why?
|
| Microarray Analysis | 1 | 2019 | 64 | 0.150 |
Why?
|
| Pyrimidines | 1 | 2020 | 130 | 0.150 |
Why?
|
| Oncogene Protein v-akt | 1 | 2018 | 20 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 206 | 0.150 |
Why?
|
| Chemokine CXCL12 | 1 | 2018 | 32 | 0.140 |
Why?
|
| Cell Nucleus | 1 | 2020 | 383 | 0.140 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2018 | 7 | 0.140 |
Why?
|
| Cell Cycle | 1 | 2019 | 348 | 0.130 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 599 | 0.130 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 522 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 744 | 0.120 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 115 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 972 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2020 | 722 | 0.120 |
Why?
|
| Growth Inhibitors | 1 | 2012 | 29 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 122 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2012 | 21 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 128 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 196 | 0.090 |
Why?
|
| Enzyme Activation | 1 | 2013 | 462 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 506 | 0.090 |
Why?
|
| DNA Primers | 1 | 2012 | 295 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2012 | 154 | 0.090 |
Why?
|
| Activin Receptors, Type I | 1 | 2011 | 3 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 454 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 457 | 0.080 |
Why?
|
| Vasopressins | 1 | 2010 | 13 | 0.080 |
Why?
|
| Pertussis Toxin | 1 | 2010 | 25 | 0.080 |
Why?
|
| Vasoconstrictor Agents | 1 | 2010 | 42 | 0.080 |
Why?
|
| Stromal Cells | 1 | 2010 | 54 | 0.080 |
Why?
|
| Base Sequence | 1 | 2012 | 997 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2011 | 574 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2012 | 426 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2012 | 633 | 0.080 |
Why?
|
| Protein Binding | 1 | 2012 | 1076 | 0.070 |
Why?
|
| Autocrine Communication | 1 | 2008 | 12 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2010 | 301 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 167 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2008 | 534 | 0.060 |
Why?
|
| Rats | 1 | 2012 | 3701 | 0.060 |
Why?
|
| Glutamates | 1 | 2024 | 23 | 0.050 |
Why?
|
| Citrates | 1 | 2024 | 20 | 0.050 |
Why?
|
| Alanine | 1 | 2024 | 33 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2024 | 36 | 0.050 |
Why?
|
| Aspartic Acid | 1 | 2024 | 51 | 0.050 |
Why?
|
| Metabolome | 1 | 2024 | 50 | 0.050 |
Why?
|
| Arginine | 1 | 2024 | 75 | 0.050 |
Why?
|
| Metabolomics | 1 | 2024 | 90 | 0.050 |
Why?
|
| Proteomics | 1 | 2023 | 363 | 0.040 |
Why?
|
| Protein Phosphatase 2 | 1 | 2020 | 25 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 733 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2020 | 103 | 0.040 |
Why?
|
| Receptors, Androgen | 1 | 2020 | 144 | 0.040 |
Why?
|
| RNA Interference | 1 | 2020 | 246 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 201 | 0.040 |
Why?
|
| Gene Expression | 1 | 2020 | 692 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3077 | 0.030 |
Why?
|
| Animals | 1 | 2012 | 16695 | 0.030 |
Why?
|